Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3723_Библиотеки_им_академика_М_И_Перельмана
.pdf
13 Native-Valve Endocarditis
https://t.me/medicina_free
179
Association Joint Committee on Clinical Practice
Guidelines. J Am Coll Cardiol. 2021;77(4):450–500.
8. Thiene G, Basso C. Pathology and pathogenesis of infective endocarditis in native heart valves.
Cardiovasc Pathol. 2006;15(5):256–63.
9. Lepeschkin E. On the relation between the site
of valvular involvement in endocarditis and the
blood pressure resting on the valve. Am J Med Sci.
1952;224(3):318–9.
10. Michel PL, Acar J. Native cardiac disease predisposing to infective endocarditis. Eur Heart J.
1995;16(Suppl B):2–6.
11. Grifn MR, Wilson WR, Edwards WD, O'Fallon
WM, Kurland LT. Infective endocarditis. Olmsted
County, Minnesota, 1950 through 1981. JAMA.
1985;254(9):1199–202.
12. van der Meer JT, Thompson J, Valkenburg HA,
Michel MF.Epidemiology of bacterial endocarditis in
The Netherlands I.Patient characteristics. Arch Intern
Med. 1992;152(9):1863–8.
13. Holland TL, Baddour LM, Bayer AS, Hoen B, Miro
JM, Fowler VG Jr. Infective endocarditis. Nat Rev Dis
Primers. 2016;2:16059.
14. Thuny F, Di Salvo G, Belliard O, Avierinos JF,
Pergola V, Rosenberg V, et al. Risk of embolism and
death in infective endocarditis: prognostic value of
echocardiography: a prospective multicenter study.
Circulation. 2005;112(1):69–75.
15. Bin Abdulhak AA, Baddour LM, Erwin PJ, Hoen
B, Chu VH, Mensah GA, etal. Global and regional
burden of infective endocarditis, 1990-2010: a
systematic review of the literature. Glob Heart.
2014;9(1):131–43.
16. Hill EE, Herijgers P, Claus P, Vanderschueren S,
Herregods MC, Peetermans WE.Infective endocarditis: changing epidemiology and predictors of 6-month
mortality: a prospective cohort study. Eur Heart J.
2007;28(2):196–203.
17. Lockhart PB, Brennan MT, Thornhill M, Michalowicz
BS, Noll J, Bahrani-Mougeot FK, et al. Poor oral
hygiene as a risk factor for infective endocarditis-related
bacteremia. J Am Dent Assoc. 2009;140(10):1238–44.
18. Pericàs JM, Llopis J, Athan E, Hernández-Meneses
M, Hannan MM, Murdoch DR, et al. Prospective
Cohort Study of Infective Endocarditis in People Who
Inject Drugs. J Am Coll Cardiol. 2021;77(5):544–55.
19. Fowler VG Jr, Miro JM, Hoen B, Cabell CH, Abrutyn
E, Rubinstein E, etal. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA.
2005;293(24):3012–21.
20. Watt G, Lacroix A, Pachirat O, Baggett HC, Raoult D,
Fournier PE, etal. Prospective comparison of infective endocarditis in Khon Kaen, Thailand and Rennes,
France. Am J Trop Med Hyg. 2015;92(4):871–4.
21. Silverman ME, Upshaw CB Jr. Extracardiac manifestations of infective endocarditis and their historical
descriptions. Am J Cardiol. 2007;100(12):1802–7.
22. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr,
Ryan T, et al. Proposed modications to the Duke
criteria for the diagnosis of infective endocarditis.
Clin Infect Dis. 2000;30(4):633–8.
23. Habib G, Badano L, Tribouilloy C, Vilacosta I,
Zamorano JL, Galderisi M, etal. Recommendations
for the practice of echocardiography in infective
endocarditis. Eur J Echocardiogr. 2010;11(2):202–19.
24. Daniel WG, Erbel R, Kasper W, Visser CA, Engberding
R, Sutherland GR, et al. Safety of transesophageal
echocardiography. A multicenter survey of 10,419
examinations. Circulation. 1991;83(3):817–21.
25. Hilberath JN, Oakes DA, Shernan SK, Bulwer BE,
D'Ambra MN, Eltzschig HK.Safety of transesophageal echocardiography. J Am Soc Echocardiogr.
2010;23(11):1115–27; quiz 220-1.
26. Seward JB, Khandheria BK, Oh JK, Freeman WK,
Tajik AJ.Critical appraisal of transesophageal echocardiography: limitations, pitfalls, and complications.
J Am Soc Echocardiogr. 1992;5(3):288–305.
27. Gould FK, Denning DW, Elliott TS, Foweraker
J, Perry JD, Prendergast BD, et al. Guidelines for
the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the
British Society for Antimicrobial Chemotherapy. J
Antimicrob Chemother. 2012;67(2):269–89.
28. Prendergast BD, Tornos P. Surgery for infective endocarditis: who and when? Circulation.
2010;121(9):1141–52.
29. Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun
SC, et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med.
2012;366(26):2466–73.
30. Kouijzer IJE, van der Meer JWM, Oyen WJG,
Bleeker-Rovers CP. Diagnostic yield of FDG-PET/
CT in fever of unknown origin: a systematic review,
meta-analysis, and Delphi exercise. Clin Radiol.
2018;73(6):588–9.
31. Hariri H, Tan S, Martineau P, Lamarche Y, Carrier
M, Finnerty V, etal. Utility of FDG-PET/CT for the
detection and characterization of sternal wound infection following sternotomy. Nucl Med Mol Imaging.
2019;53(4):253–62.
32. Rojoa D, Kontopodis N, Antoniou SA, Ioannou CV,
Antoniou GA. 18F-FDG PET in the diagnosis of
vascular prosthetic graft infection: a diagnostic test
accuracy meta-analysis. Eur J Vasc Endovasc Surg.
2019;57(2):292–301.
33. Glaudemans AW, de Vries EF, Galli F, Dierckx RA,
Slart RH, Signore A. The use of (18)F-FDG-PET/
CT for diagnosis and treatment monitoring of inam-

180
https://t.me/medicina_free
G. Abikhzer et al.
matory and infectious diseases. Clin Dev Immunol.
2013;2013:623036.
34. Sarrazin JF, Philippon F, Tessier M, Guimond J, Molin
F, Champagne J, et al. Usefulness of uorine-18
positron emission tomography/computed tomography for identication of cardiovascular implantable electronic device infections. J Am Coll Cardiol.
2012;59(18):1616–25.
35. Abikhzer G, Turpin S, Bigras JL.Infected pacemaker
causing septic lung emboli detected on FDG PET/
CT.J Nucl Cardiol. 2010;17(3):514–5.
36. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG,
Casalta JP, Del Zotti F, et al. 2015 ESC Guidelines
for the management of infective endocarditis:
The Task Force for the Management of Infective
Endocarditis of the European Society of Cardiology
(ESC). Endorsed by: European Association for
Cardio-Thoracic Surgery (EACTS), the European
Association of Nuclear Medicine (EANM). Eur Heart
J. 2015;36(44):3075–128.
37. Pizzi MN, Roque A, Fernandez-Hidalgo N, CuellarCalabria H, Ferreira-Gonzalez I, Gonzalez-Alujas
MT, etal. Improving the diagnosis of infective endocarditis in prosthetic valves and intracardiac devices
with 18f-uordeoxyglucose positron emission tomography/computed tomography angiography: initial
results at an Infective Endocarditis Referral Center.
Circulation. 2015;132(12):1113–26.
38. Vaidyanathan S, Patel CN, Scarsbrook AF, Chowdhury
FU. FDG PET/CT in infection and inammation—
current and emerging clinical applications. Clin
Radiol. 2015;70(7):787–800.
39. Manabe O, Yoshinaga K, Ohira H, Masuda A, Sato T,
Tsujino I, etal. The effects of 18-h fasting with lowcarbohydrate diet preparation on suppressed physiological myocardial (18)F-uorodeoxyglucose (FDG)
uptake and possible minimal effects of unfractionated
heparin use in patients with suspected cardiac involvement sarcoidosis. J Nucl Cardiol. 2016;23(2):244–52.
40. Soussan M, Brillet PY, Nunes H, Pop G, Ouvrier MJ,
Naggara N, etal. Clinical value of a high-fat and lowcarbohydrate diet before FDG-PET/CT for evaluation
of patients with suspected cardiac sarcoidosis. J Nucl
Cardiol. 2013;20(1):120–7.
41. Slart R, Glaudemans A, Gheysens O, Lubberink
M, Kero T, Dweck MR, et al. Procedural recommendations of cardiac PET/CT imaging: standardization in inammatory-, infective-, inltrative-,
and innervation- (4Is) related cardiovascular diseases: a joint collaboration of the EACVI and the
EANM: summary. Eur Heart J Cardiovasc Imaging.
2020;21(12):1320–30.
42. Martineau PP-GM, Juneau D, Leung E, Birnie
D, Beanlands RSB. Molecular imaging of cardiac sarcoidosis. Curr Cardiovasc Imaging Rep.
2018;11(6):6–17.
43. Chen W, Dilsizian V. Molecular imaging of cardiovascular device infection: targeting the bacteria or
the host-pathogen immune response? J Nucl Med.
2020;61(3):319–26.
44. Juneau D, Pelletier-Galarneau M.Revisiting the relevance of the 3-month safety period in the evaluation
of prosthetic valve endocarditis with FDG-PET/CT.J
Nucl Cardiol. 2020;28(5):2269–71.
45. Kamani CH, Allenbach G, Jreige M, Pavon AG,
Meyer M, Testart N, et al. Diagnostic performance
of (18)F-FDG PET/CT in native valve endocarditis: systematic review and bivariate meta-analysis.
Diagnostics. 2020;10(10):754.
46. Salomaki SP, Saraste A, Kemppainen J, Bax JJ, Knuuti
J, Nuutila P, et al. (18)F-FDG positron emission
tomography/computed tomography in infective endocarditis. J Nucl Cardiol. 2017;24(1):195–206.
47. Granados U, Fuster D, Pericas JM, Llopis JL, Ninot
S, Quintana E, etal. Diagnostic accuracy of 18F-FDG
PET/CT in infective endocarditis and implantable
cardiac electronic device infection: a cross-sectional
study. J Nucl Med. 2016;57(11):1726–32.
48. Kouijzer IJE, Berrevoets MAH, Aarntzen E,
de Vries J, van Dijk APJ, Oyen WJG, et al.
18F-uorodeoxyglucose positron-emission tomography combined with computed tomography as a
diagnostic tool in native valve endocarditis. Nucl Med
Commun. 2018;39(8):747–52.
49. Philip M, Delcourt S, Mancini J, Tessonnier
L, Cammilleri S, Arregle F, et al. (18)
F-uorodeoxyglucose positron emission tomography/
computed tomography for the diagnosis of native
valve infective endocarditis: a prospective study. Arch
Cardiovasc Dis. 2021;114(3):211–20.
50. de Camargo RA, Sommer Bitencourt M, Meneghetti
JC, Soares J, Goncalves LFT, Buchpiguel CA,
et al. The role of 18F-Fluorodeoxyglucose positron emission tomography/computed tomography
in the diagnosis of left-sided endocarditis: native
vs. prosthetic valves endocarditis. Clin Infect Dis.
2020;70(4):583–94.
51. Habib G, Erba PA, Iung B, Donal E, Cosyns B,
Laroche C, et al. Clinical presentation, aetiology
and outcome of infective endocarditis. Results of
the ESC-EORP EURO-ENDO (European infective
endocarditis) registry: a prospective cohort study. Eur
Heart J. 2019;40(39):3222–32.
52. Duval X, Le Moing V, Tubiana S, Esposito-Farese M,
Ilic-Habensus E, Leclercq F, etal. Impact of systematic whole-body 18F-uorodeoxyglucose PET/CT
on the management of patients suspected of infective
endocarditis: the prospective multicenter TEPvENDO
study. Clin Infect Dis. 2020;73(3):393–403.
53. Hsu DFC, Ilan E, Peterson WT, Uribe J, Lubberink
M, Levin CS. Studies of a next-generation siliconphotomultiplier- based time-of-ight PET/CT system.
J Nucl Med. 2017;58(9):1511–8.
54. Boursier C, Duval X, Bourdon A, Imbert L, Mahida
B, Chevalier E, etal. ECG-gated cardiac FDG PET
acquisitions signicantly improve detectability of
infective endocarditis. JACC Cardiovasc Imaging.
2020;13(12):2691–3.
55. Wang TKM, Sanchez-Nadales A, Igbinomwanhia E,
Cremer P, Grifn B, Xu B.Diagnosis of infective endo-

13 Native-Valve Endocarditis
https://t.me/medicina_free
181
carditis by subtype using (18)F-Fluorodeoxyglucose
positron emission tomography/computed tomography: a contemporary meta-analysis. Circ Cardiovasc
Imaging. 2020;13(6):e010600.
56. Holle SLK, Andersen MH, Klein CF, Bruun NE,
Tonder N, Haarmark C, et al. Clinical usefulness
of FDG-PET/CT for identication of abnormal
extra- cardiac foci in patients with infective endocarditis. Int J Cardiovasc Imaging. 2020;36(5):
939–46.
57. Boursier C, Duval X, Mahida B, Hoen B, Goehringer
F, Selton-Suty C, etal. Hypermetabolism of the spleen
or bone marrow is an additional albeit indirect sign of
infective endocarditis at FDG-PET. J Nucl Cardiol.
2020;28(6):2533–42.
58. Thuny F, Beurtheret S, Mancini J, Gariboldi V, Casalta
JP, Riberi A, et al. The timing of surgery inuences
mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis.
Eur Heart J. 2011;32(16):2027–33.
59. Chen W, Dilsizian V. FDG PET/CT for the diagnosis and management of infective endocarditis:
expert consensus vs. evidence-based practice. J Nucl
Cardiol. 2019;26(1):313–5.
60. Otto CM, Nishimura RA, Bonow RO, Carabello
BA, Erwin JP 3rd, Gentile F, et al. 2020 ACC/AHA
guideline for the management of patients with
valvular heart disease: a report of the American
College of Cardiology/American Heart Association
Joint Committee on Clinical Practice Guidelines.
Circulation. 2021;143(5):e72–e227.
61. Kestler M, Munoz P, Rodriguez-Creixems M, Rotger
A, Jimenez-Requena F, Mari A, etal. Role of (18)
F-FDG PET in patients with infectious endocarditis. J
Nucl Med. 2014;55(7):1093–8.
62. San S, Ravis E, Tessonier L, Philip M, Cammilleri
S, Lavagna F, et al. Prognostic value of (18)
F-uorodeoxyglucose positron emission tomography/
computed tomography in infective endocarditis. J Am
Coll Cardiol. 2019;74(8):1031–40.

Cardiovascular Implantable
https://t.me/medicina_free
Electronic Device Infection
BesmaMahida, JérémieCalais,
andFrançoisRouzet
14
Introduction
Cardiac Implantable Electronic
Device (CIED) Infections
Cardiac implantable electronic device (CIED)
implantations, such as pacemakers, cardiac
resynchronization therapy devices, and implantable cardiac debrillators, have signicantly
increased in number in the past decades [1] as the
indications are continuously expanding and
because of the aging of the population. Despite
improvements of CIED designs and preventive
measures, CIED infection incidence, morbidity,
mortality [2] are still increasing and represent an
economic burden [3].
CIED infection mainly results from generator
pocket contamination during implantation [4]
with a risk of spread to the leads resulting in cardiac device-related infective endocarditis
(CDRIE) [2, 5]. Less frequently, CIED infection
B. Mahida · F. Rouzet (*)
APHP, Service de Médecine Nucléaire, Hôpital
Bichat, Paris, France
Université Paris Cité, Paris, France
Inserm U1148, Paris, France
e-mail: francois.rouzet@aphp.fr
J. Calais
Ahmanson Translational Theranostics Division,
Department of Molecular and Medical Pharmacology,
David Geffen School of Medicine, UCLA,
Los Angeles, CA, USA
results from hematogenous contamination from a
distant focal infection [4]. Since CIED infection
involves most frequently the generator pocket,
the main infectious agents responsible for CIED
infections are Gram-positive organisms, predominantly staphylococcal species. The virulence
factors of the infectious agents are their ability to
initiate microbial adhesion to the device surface
and to produce a thick multilayered biolm concurring to resistance to antibiotic therapy [6].
The most frequent clinical signs of CIED
infection are the consequence of local reaction
to generator pocket infection that include erythema, pain, swelling, tenderness, discharge, or
ulceration [7]. However, these local signs can be
missing and CIED systemic infection or CDRIE
might have misleading presentation with nonspecic symptoms such as fever, chills, night sweats,
or distant septic embolic events (pulmonary,
spondylodiscitis) [8, 9]. The diagnostic work-up
of CIED infection and/or CDRIE is based on the
modied Duke-Li criteria that combine clinical
ndings, laboratory tests, bacterial cultures (blood
and extracted device), and evidence of vegetation
on lead or valve by transesophageal echocardiography (TEE) or other imaging modalities [2].
However, the nal diagnosis may be challenging,
given the variety of clinical presentations and the
artifacts of echocardiography due to prosthetic
materials [10]. Because therapeutic management of CIED infection/CDRIE often results in
complete system removal and/or prolonged anti-
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2022
M. Pelletier-Galarneau, P. Martineau (eds.), FDG-PET/CT and PET/MR in Cardiovascular
Diseases, https://doi.org/10.1007/978-3-031-09807-9_14
183

184
https://t.me/medicina_free
B. Mahida et al.
biotic therapy [2, 11], an accurate diagnosis is
necessary. Recently, the European Societies [2]
included as a class 1 recommendation nuclear
imaging with both 18F-urodeoxyglucose (FDG)
positron emission tomography/computed tomography (PET/CT) and radiolabeled white blood
cell (WBC) single-photon emission computed
tomography/computed tomography (SPECT)/CT
in the diagnostic criteria.
For inammatory and infectious diseases indications, FDG PET/CT signal relies on metabolic
activity at sites with high concentrations of activated neutrophils and monocyte/macrophages
with increased glucose transporters (GLUT) and
hexokinase (HK) expression [12].
Left Ventricular Assist Device (LVAD)
Infection
Left ventricular assist device (LVAD) is s a lifesaving therapy for patients with advanced
chronic heart failure, as a bridge to heart transplant or as destination therapy. As LVAD
implantations are increasing due to a shortage in
organ donations, LVAD infections are rising
[13]. LVAD infection is associated with higher
risk of pump thrombosis, longer hospital stay
duration, requirement for LVAD replacement,
and failure to transplant [14].
LVAD infection was described by the
International Society for Heart and Lung
Transplantation (ISHLT) and classied into (1)
“VAD-specic infections,” referring to the infection of the hardware components or the body surfaces containing them (including infections of the
pump, cannula, anastomoses, the pocket infections,
and the percutaneous driveline or tunnel); (2)
“VAD-related infections,” referring to IE, bloodstream infection and mediastinitis with high infection mortality rating at 70% in VAD- related IE and
mediastinitis; and (3) “non-VAD infections,” referring to septic events that are not directly related to
the presence of the LVAD hardware [15].
The most frequent type of LVAD infection occurs on the driveline, commonly from
pathogens of the skin microbiome, including S.
aureus, coagulase negative staphylococci and
Corynebacterium spp., while Candida is less fre-
quently found [16].
Currently, there are no standard guidelines
for LVAD infection diagnosis management;
therefore, the impact of nuclear medicine
imaging is not yet well established in LVAD
infections. However, recent studies reported on
the usefulness of FDG PET/CT and/or comparison with WBC SPECT/CT in localizing
and assessing the site of LVAD infection
[17–21].
Diagnostic Work-Up ofCIED
andLVAD Infections
Clinical Signs
Due to the variety and absence of specicity of
symptoms, the diagnosis of CIED infection is challenging. Infections involve most frequently the generator pocket. Localized generator pocket infection
signs range from pocket wound inammation to
external purulent drainage of the device [22].
In the presence of exposed generator or proximal leads, the CIED should be considered
infected regardless of microbiology results.
Therefore, assessing the potential extension of
CIED infection is important for therapy management. Supercial infection of the pocket wound
does not require total hardware extraction as it
concerns the cutaneous and subcutaneous tissues,
allowing a conservative treatment while generator pocket infection, which can be associated
with lead infection, CIED systemic sepsis, and/or
CDRIE [23], requires a more invasive strategy.
In the absence of visible signs of local infection, CIED systemic infection and CDRIE diagnosis are more challenging with predominantly
nonspecic symptoms such as distant septic
emboli, mainly pulmonary [24], or vertebral osteomyelitis and discitis [9]. Similarly, the diagnosis of
LVAD infection is challenging because clinical
presentation may range from nonspecic symptoms such as erythema, warmth, to purulent drainage around the driveline exit site and the difculty
to localize the infection source, involving either
supercial or deep components of the device [25].

14 Cardiovascular Implantable Electronic Device Infection
https://t.me/medicina_free
185
Microbiology
Most pathogens responsible for CIED and LVAD
infections are cutaneous organisms considering
that infections most frequently originate from the
generator pocket or the percutaneous driveline.
However, cultures sampled from blood and from
any suspected infected site(s) should be systematically performed before antibiotics initiation in
patients with CIED who develop fever without
typical signs of local infection.
Imaging
The 2019 European Society of Cardiology (ESC)
recommendations for CIED infection diagnosis
management [2] rely on multimodality imaging
that includes FDG PET/CT and WBC SPECT/
CT along with echography and CT.
Echocardiography
Transthoracic echocardiography (TTE) and
transesophageal echocardiography (TEE) are
recommended for the assessment of lead vegetation and/or valvular involvement in suspected
CIED infections with a clear superiority of TEE
for vegetation detection and size measurement
[2, 26]. Echocardiography remains the rst-line
diagnostic tool in the assessment of patients with
CIED infection or CDRIE suspicion. However,
limitations and inconclusive cases impair the
Duke-Li classication sensitivity [10].
Cardiac CT
Cardiac contrast-enhanced (CE) computed
tomography (CT) provides anatomical information to detect the presence of vegetations and
local complications such as abscesses, pseudoaneurysms, stulas, or septic embolization [27].
The 2015 ESC modied criteria for the diagnosis
of IE included cardiac CT in the assessment of
paravalvular lesions as a major criterion for IE
diagnosis, which might allow the diagnosis of
CDRIE. However, CE-CT can be limited by
iodinated contrast agent contraindication and the
presence of metallic artifacts generated by the
CIED or LVAD hardware.
Endocarditis Team
The recent 2019 ESC consensus on CIED infection highlighted the role of a multidisciplinary
approach that includes cardiologists, cardiovascular surgeons, infectious diseases specialists,
clinical microbiologists, echocardiographers,
radiologists, and nuclear medicine physicians. A
multidisciplinary approach can signicantly
reduce the 1-year mortality of IE [28].
Prognosis
The prognosis of patients with infected CIED is
poor, with a mortality rate of 5%–8% at 30-day
and 20% at 1year due to cardiac and extracardiac
complications [29, 30]. Patients with comorbidities have a higher mortality rate. CIED infection
remains a serious, life-threatening condition that
requires usually the complete removal of the
hardware, as a delay in device removal might
worsen prognosis [31].
FDG PET/CT
Basic Principles
FDG PET/CT is a nuclear imaging modality
often used for assessing infectious and inammatory diseases. Fluorine-18 (18F) is a cyclotronproduced radioisotope with a half-life of
109.7 min that decays by emitting positrons,
which can be detected with a PET scanner. 18FFDG is a glucose analogue, which enters cells via
glucose transporter (GLUT), and then undergoes
phosphorylation by hexokinase (HK). However,
phosphorylated 18F-FDG is a metabolic dead
end, which accumulates within cells during the
1-h delay separating injection from acquisition
resulting in major signal amplication.

186
https://t.me/medicina_free
B. Mahida et al.
Inammatory cells (activated neutrophils, macrophages, monocytes, and lymphocytes) express
high levels of glucose transporters, especially
GLUT1 and GLUT3, and have hexokinase activity, which translate into an increased FDG uptake
[32]. The European Association of Nuclear
Medicine and the Society of Nuclear Medicine
issued guidelines for performing FDG PET/CT
in patients with suspected infection [33].
Patient Preparation
The main goal is to inhibit physiological myocardial FDG uptake to enable the visualization of
increased FDG signal foci. This can be achieved
by combining a no-carbohydrate high-fat meal
>12 h before the scan and a fasting period of
>12h [34]. As usual with FDG PET, pregnancy,
diabetes, and serum glucose level should be
checked before FDG injection [33].
Tracer Administration
In Europe the recommended administered activity of FDG ranges between 2.5 and 5.0MBq/kg.
In the United States, it ranges between 370 and
740 MBq. Administered activity should be
adapted for infants and children according to
pediatric dosage. In case of suspected CIED
infection, radiopharmaceuticals should be administrated in the contralateral arm to avoid the
potential pitfall of accumulated FDG along the
leads mimicking septic locations [33].
Imaging Procedure
The image acquisition should be performed
60min after FDG administration, from vertex to
toes (total-body acquisition) for the detection of
distant septic emboli, in whole-body mode, using
steps of 1.5–3min per bed position. CT acquisition parameters can be used as detailed in the
EANM tumor imaging guidelines [35] and
always adapted to the CT scanner performance
and to the specic radiologic society guidelines.
PET images should be reconstructed using cor-
rections for attenuation, dead time, random
events, and scatter, according to the PET/CT
scanner performance. Whenever possible, ECGgated acquisitions in the thorax should be performed as it improves EI detection and might be
helpful with CDRIE diagnosis [36].
Interpretation Criteria
The analysis of the FDG PET/CT images relies
on visual criteria. Both attenuation-corrected
(AC) and non-attenuation-corrected (NAC)
images centered on the CIED should be analyzed
carefully by scrolling through each of the axial,
coronal, and sagittal views of the PET only, CT
only, fused PET/CT images. The local analysis
should focus on the signal around the generatorpocket site, along the leads and in the valves.
Increased FDG uptake above the background
around CIED generator-pocket and leads (extravascular, intravascular, or intracardiac) should be
considered suspicious. The 3D MIP images and
the whole-body FDG PET/CT images should be
carefully analyzed for the detection of other foci
of infection which could represent the primary
site of infection or distant secondary septic locations (lungs, spleen, spine, mycotic aneurysms).
The main cause of false-positive FDG-PET is
inammation (acute, sub-acute, chronic) caused
by the surgery or the presence of foreign body.
Therefore, the time from CIED implantation to
imaging is crucial information that must be collected and incorporated in the overall interpretation of the study.
The nal FDG PET/CT diagnosis of CIED
infection relies on the combination of multiple
features. Visual analysis is the method of reference. The semi-quantitative parameters do not
allow the differentiation of infection vs. inammation (range values overlap) and should be used
only as a complement to the visual analysis.
Signs in favor of infection include highintensity uptake, uptake visible on both AC and
NAC images, focal uptake on the leads, heterogeneous and intense signal around the generator,
continuity of the FDG PET signal to the surrounding tissues (muscle, skin), presence of distant septic locations (especially in the lungs), and

14 Cardiovascular Implantable Electronic Device Infection
https://t.me/medicina_free
187
time from CIED implantation to imaging of
>2 months. Signs that do not suggest infection
include uptake visible only on the AC or the
NAC, diffuse and homogeneous moderate uptake,
presence of metallic artifacts, and time from
CIED implantation to imaging of <2months.
Factors that decrease the intensity of the signal
and thus the sensitivity of the scan include exposure to antibiotic therapy, metallic artifacts, partial
volume effect, and motion artifacts. Whenever
possible, the scan should be performed as early as
possible in the course of the disease before treatment initiation and include ECG- gated acquisitions centered on the thorax. The use of CT
contrast may enhance the visualization of the anatomic structures and thus be helpful in some cases.
Although FDG PET/CT offers the possibility
of semi-quantitative analysis, current available
studies describing the use of values such as a
maximum standardized uptake value (SUV
max
) or
a semi-quantitative ratio (SQR) to assess areas of
FDG uptake did not report a signicant improvement in discriminating infected from noninfected devices [37]. The visual analysis is the
method of reference, especially for CDRIE
detection.
CIED Infections
Recently, the use of nuclear medicine imaging in
suspected CIED infection and CDRIE has
increased, especially in cases of suspected CIED
infections with no local signs of infection at generator pocket and non-conclusive echocardiography. In these challenging situations, the 2019
ESC guidelines recommend [2] total-body FDG
PET/CT to assess the extent of disease, with distant septic emboli being considered as a minor
criterion for CIED infection diagnosis, and to
localize the portal of entry.
Two recent meta-analyses by Juneau et al.
[38] and Mahmood etal. [37] reported high sensitivity and specicity of FDG PET/CT for the
diagnosis of CIED infection: pooled sensitivity
of 87% (95% CI, 82–91%) and 83% (95% CI
78–86%), and pooled specicity of 94% (95%
CI, 88–98%) and 89 (95% CI 84–94%), respectively. Mahmood etal. estimated a higher sensi-
tivity of 96% (95% CI 86–99%) and specicity
of 97% (95% CI 86–99%) for pocket infection
diagnosis. Although generator pocket infection
is mainly a clinical diagnosis, FDG PET/CT can
be useful in situations with uncertain diagnosis
[39]. The diagnostic accuracy for the detection
of lead infections or CDRIE is lower with a
reported sensitivity and specicity of 76% (95%
CI 65–85%) and 83% (95% CI 72–90%),
respectively [37]. The main technical limitations are the partial volume effect and cardiac
motion artifact.
Extracardiac complications occur in 30–80%
of patients [40, 41] and are known to increase
mortality and worsen prognosis [42]. The ability
of FDG PET/CT to detect distant extracardiac
complications such as septic emboli and metastatic infection provides incremental diagnostic
and prognostic information for CIED infection
and CDRIE [2, 43]. Septic pulmonary emboli
and spondylodiscitis are the most frequent distant
infectious sites [9]. Septic pulmonary emboli are
a common nding in CIED lead infection and
CDRIE involving tricuspid valve infection. The
presence of multiple and bilateral foci of FDG
uptake, often associated with matching parenchymal opacities on CT, is highly suggestive of
septic emboli and accordingly of infection of the
device [44]. In a prospective study, Amraoui etal.
evaluated 35 patients with a denite diagnosis of
CDRIE by Duke-Li criteria, and spondylodiscitis
was identied on FDG PET/CT in 20% of
patients, some being completely asymptomatic
[45]. Vascular septic emboli and mycotic aneurysms are usually asymptomatic but might lead to
vascular rupture, a life-threatening complication
(Fig.14.1). The most common localization is in
the brain and can be detected by MRI; however, it
might occur anywhere else [46–48] (Fig.14.2).
The other frequent sites of septic emboli are the
same as encountered in IE and include the spleen
and bone marrow. Boursier etal. demonstrated,
in a cohort of 129 patients including 88 subjects
with a denite diagnosis of IE, that diffuse high
FDG uptake in the spleen and/or bone marrow
(dened as superior to liver uptake) can be an
indirect sign of IE [49].
Although FDG PET/CT has an added value to
the modied Duke-Li criteria for the diagnosis of

188
ab
https://t.me/medicina_free
B. Mahida et al.
c
d
f
Fig. 14.1 An 83-year-old male who underwent cardiac
electronic device (CIED) implantation 5years prior. The
patient had native mitral endocarditis. EI diagnosis was
based on the visualization of a vegetation on echocardiography and positive E. faecalis blood cultures.
18F-urodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) scan did not show
signicant uptake on the native mitral valve. However, it
showed intense FDG uptake (yellow arrows) on distant
sites along the PM lead, L2-L3 vertebrae, and the tibial
bular arterial trunk ((a) whole body FDG PET maximum
e
g
intensity projection images). (b) Axial FDG PET. (c)
Fused axial PET/CT chest images showed intense uptake
along the PM lead. Extraction of the device conrmed the
lead infection. (d) Axial FDG PET. (e) Fused axial PET/
CT spine images showed intense FDG uptake on L2-L3
suspicious for spondylodiscitis that was conrmed on
MRI—the patient was asymptomatic. (f) Axial FDG PET.
(g) Fused axial PET/CT of the lower limbs showed focal
uptake on the tibial bular arterial trunk suggesting
mycotic aneurysm
CIED infections [44, 50], it is important to point
out the limitations of the technique. The main
limitation is the lack of specicity of FDG uptake
for infection as FDG also accumulates at sites of
aseptic inammation. This can lead to false-positive cases, especially in the immediate period
after device implantation, or in patients with
intense inammatory reaction to foreign body.
Another important factor to consider is the delay
between antibiotics initiation and the scan: sensitivity decreases with duration of the antimicrobial
therapy [44, 51]. FDG PET/CT should be performed as early as possible when CIED infection
is suspected.

14 Cardiovascular Implantable Electronic Device Infection
https://t.me/medicina_free
189
bad
eg
Fig. 14.2 A 75-year-old female with a prior history of
CIED infection 2 years earlier. The patient underwent
generator removal but only partial leads extraction. The
patient had persistent episodes of fever and positive
MRSA blood cultures. Echocardiography was inconclusive. The FDG PET/CT scan showed no abnormal uptake
on the remaining lead ((a) fused coronal PET/CT) but sig-
LVAD Infections
In their case series, systematic review, and metaanalysis, Tam etal. analyzed the diagnostic accuracy of FDG PET/CT in suspected LVAD
infections [20]. Despite limited data, they reported
a high sensitivity of 92% (95%CI: 82–97%) and a
more variable specicity of 83% (95% CI:
24–99%). The limitations that impair FDG PET/
CT specicity for the diagnostic of CIED infection
also apply with LVAD. Kim et al. evaluated the
impact of FDG PET/CT on patient management
and outcome in LVAD infections [18]. FDG PET/
c
f
nicant intense focal uptake in the right lung (yellow
arrows) (PET axial images (c and f)) corresponding to a
lung parenchymal opacity on fused axial PET/CT images
(b and e) and axial CT images (d and g). FDG PET/CT
images of septic lung emboli helped to diagnose the CIED
infection. The patient was treated with suppressive antibiotic therapy
CT localized infection among 28 of the 35 patients
analyzed. According to FDG PET/CT ndings,
patients were considered as noninfected, infected
with peripheral infection limited to the exit wound
site and/or driveline, or infected with central infection extending to components of the LVAD (cannula and/or pump pocket). During the follow-up,
the majority of deaths occurred in patients with
central versus peripheral infection groups, and
none of the noninfected patients died. FDG PET/
CT should be performed in early stages of suspected LVAD infection to obtain the best impact
on the patient management (Fig.14.3).
Соседние файлы в папке Библиотека им академика М.И. Перельмана
